Materials and instruments. All reagents were purchased from commercial suppliers and used without further purification. Solvents were purified by standard methods. All solutions were prepared using ultrapure water, which was prepared through a Millipore Milli-Q water purification system (Billerica, MA, USA). TLC analysis was performed on silica gel plates, and column chromatography was conducted over silica gel (mesh 200-300), both of which were obtained from Qingdao Ocean Chemicals. 1 H and 13 C NMR spectra were recorded on a Bruker DRX-400 spectrometer operating at 400 and 100 MHz with chemical shifts reported as ppm (in DMSO-d6, TMS as internal standard).
Mass spectrometric data LC-MS analyses were performed using an Agilent 1100 HPLC/MSD spectrometer. The pH measurements were carried out on a Mettler-Toledo Delta 320 pH meter. UVvis absorption spectra were recorded with a Shimadzu UV-2450 spectrophotometer. 
where ΦF is the fluorescence quantum yield, A is the absorbance at the excitation wavelength, F is the area under the corrected emission curve, and n is the refractive index of the solvents used.
Subscripts s and x refer to the standard and to the unknown, respectively. The solutions of compounds HN1-7, rhodamine B, Cy5 and standards were kept absorptions below 0.05. For comparative experiments, the blank group was anesthetized without any treatment. The second group was given an intraperitoneal injection of Cy5 (5 nanomoles). The third group was given an intraperitoneal injection of HN7 (5 nanomoles).
For analyte detection in vivo, the control group was only given an intraperitoneal injection of probe (HN7-N2 or HN7-S). The second group was given an intraperitoneal injection with probe, followed by intraperitoneal injection with analyte (NO or Hg 2+ ) after 30 min.
Before imaging, the mice were anesthetized by inhalation of 5% isoflurane in 100% oxygen. The animals were placed into the imaging chamber and kept under anesthetic using an isoflurane gas anesthesia system. The nude mice were imaged using a Caliper VIS Lumina XR small animal optical in vivo imaging system. Unless otherwise stated, imaging mode for all experiments was set as excitation scan, and Input/Em was chosen as 605 nm for excitation with Cy5.5 filter for emission channel. All fluorescence images were acquired with autoexposure (FOV, 10 cm; f/stop 2; bin, high resolution), and fluorescence intensity was scaled as units of photons per second per square centimeter per steradian (ps -1 cm -2 sr -1 ).
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Synthesis
Synthesis of HN1-6. 2-(4-diethylamino-2-hydroxybenzoyl)-benzoic acid (3 mmol) and Nsubstituent ketone (3 mmol) were added to concentrated H 2 SO 4 (15 mL) at 0 °C. The reaction mixture was heated at 90 °C for 1.5 h, cooled down, and poured onto ice. Perchloric acid (70%, 1 mL) was then added. The resulting precipitate was filtered off and washed with cold water (100 mL), which was purified by silica gel flash chromatography using CH 2 Cl 2 to CH 2 Cl 2 /ethanol (100:1 to 20:1) as eluent to afford HN1-6 as a purple-green solid (yield > 80%).
HN1
. 1 
Synthesis of HN7.
Dimethyl phthalate (4 g, 20.6 mmol) and 6-dimethylamino-3, 4-dihydro-1(2H)-naphthalenone (378 mg, 2 mmol) were dissolved in dry THF (100 mL), and then NaH in PE (1 g) was added under an atmosphere of nitrogen. The mixture was stirred at 60 °C for 24 h and then poured into ice water. HCl (6 M) was added to neutralize excess base. The mixture was extracted with CH 2 Cl 2 three times, and the organic phase was combined and dried over sodium sulfate. After removal of solvent, the yellow residue β-diketones, HN7 dye intermediate was used directly without further purification. Then β-diketones, HN7 dye intermediate and 6-dimethylamino-3,4-dihydro-1(2H)-naphthalenone (378 mg, 2 mmol) were added to concentrated H 2 SO 4 (10 mL) at 0 °C. The reaction mixture was heated at 90 °C for 4 h, cooled down, and poured onto ice. Perchloric acid (70%, 1 mL) was then added, and the resulting precipitate was filtered off and washed with cold water (100 mL), which was purified by silica gel flash chromatography using CH 2 Cl 2 to CH 2 Cl 2 /ethanol (200:1 to 20:1) as eluent to afford HN7 as a green solid (yield: 27%). HN7. 1 Synthesis of HN7-N2. Route 1: To a CH 2 Cl 2 solution (30 mL) of HN7 (98 mg, 0.2 mmol), DCC (41 mg, 0.2 mmol) and DMAP (2.5 mg, 0.02 mmol) were added at room temperature in the dark, and the mixture was stirred for 0.5 h. After o-phenylenediamine (215 mg, 2 mmol) was added, the solution was stirred for 6 h. The solvent was removed under reduced pressure, and the residue was purified by silica gel flash column chromatography using petroleum ether/ethyl acetate (10:1 to 3:1) as eluent to afford HN7-N2 as a pale yellow solid (yield: 53%).
Route 2: Phosphorus oxychloride (0.5 mL) was carefully added dropwise to a stirred solution of HN7 (98 mg, 0.2 mmol) in 1,2-dichloroethane (20 mL) over 1 min, and the mixture was then refluxed for 4 h. After cooling down to room temperature, the solvent was removed under reduced pressure to provide HN7 acyl chloride as glutinous oil. The residue was added to dry acetonitrile (10 mL) to form a solution to which a solution of o-phenylenediamine (435 mg, 4 mmol) and triethylamine (1 mL, 7.17 mmol) in dry acetonitrile (5 mL) was added dropwise. The mixture was stirred overnight at room temperature. After the solvent was removed under reduced pressure, the residue was redissolved in CH 2 Cl 2 and washed with water (100 mL × 3). The organic phase was then dried over anhydrous sodium sulfate. The solvent was removed under reduced pressure, and the residue was purified by silica gel flash column chromatography using petroleum ether/ethyl acetate (10:1 to 3:1) as eluent to afford HN7-N2 as a pale yellow solid (yield: 31%). 1 
HN7-N2.
